▲ +103.65% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for IMAC in the last 3 months. The average price target is $3.63, with a high forecast of $4.50 and a low forecast of $2.75. The average price target represents a 103.65% upside from the last price of $1.78.
The current consensus among 2 contributing investment analysts is to buy stock in IMAC. This rating has held steady since March 2020, when it changed from a Hold consensus rating.
IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of March 26, 2020, the company owned or managed 14 outpatient clinics in Kentucky, Missouri, Tennessee, and Illinois. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.